Department of Medicine, University of British Columbia, Vancouver V6Z 2K5, BC, Canada.
World J Gastroenterol. 2024 Jul 7;30(25):3126-3131. doi: 10.3748/wjg.v30.i25.3126.
Minimally invasive innovations have transformed coloproctology. Specific to colorectal cancer (CRC), there has been a shift towards less invasive surgical techniques and use of endoscopic resection as an alternative for low risk T1 CRC. The role of endoscopic resection is however much more extensive: It is now considered the first line management strategy for most large (≥ 20 mm) non-pedunculated colorectal polyps, the majority of which are benign. This is due to the well-established efficacy, safety, and cost-effectiveness of endoscopic techniques compared to surgery. Multiple endoscopic modalities now exist with distinct risk-benefit profiles and their outcomes are further improved by site-specific technical modifications, auxiliary techniques, and adverse event mitigation strategies. Endoscopic capacity continues to evolve with emerging endoscopic techniques and expanding applications, particularly in the confines of a multi-disciplinary setting.
微创创新已经改变了结直肠领域。具体到结直肠癌（CRC），已经转向了创伤更小的手术技术，并且将内镜下切除作为低危 T1 CRC 的替代方法。然而，内镜下切除的作用要广泛得多：它现在被认为是大多数（≥20mm）非息肉样大型结直肠息肉的一线治疗策略，其中大多数是良性的。这是由于内镜技术在疗效、安全性和成本效益方面明显优于手术。现在存在多种内镜方法，具有不同的风险效益特征，通过特定部位的技术改进、辅助技术和不良事件缓解策略，其结果得到进一步改善。随着新兴内镜技术和应用的不断发展，内镜能力也在不断发展，特别是在多学科环境中。
